Arteris (AIP)
(Real Time Quote from BATS)
$6.77 USD
-0.28 (-3.97%)
Updated Sep 9, 2024 02:06 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Income Statements
Fiscal Year end for Arteris, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 54 | 50 | 38 | 32 | NA |
Cost Of Goods | 5 | 4 | 4 | 1 | NA |
Gross Profit | 49 | 46 | 34 | 30 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 84 | 75 | 56 | 34 | 0 |
Income After Depreciation & Amortization | -35 | -29 | -22 | -4 | 0 |
Non-Operating Income | 4 | 1 | -1 | 2 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -32 | -28 | -22 | -2 | NA |
Income Taxes | 2 | 0 | 1 | 1 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | -3 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -37 | -27 | -23 | -3 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -37 | -27 | -23 | -3 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -33 | -27 | -20 | -3 | 0 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 1 | 1 | NA |
Income After Depreciation & Amortization | -35 | -29 | -22 | -4 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.68 | 32.58 | 21.97 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.01 | -0.81 | -1.03 | NA | NA |
Diluted Net EPS (GAAP) | -1.03 | -0.84 | -1.06 | NA | NA |
Fiscal Year end for Arteris, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 14.58 | 12.95 | 12.50 | 13.27 | 14.73 |
Cost Of Goods | 1.46 | 1.47 | 1.45 | 1.28 | 1.23 |
Gross Profit | 13.12 | 11.48 | 11.06 | 11.99 | 13.51 |
SG&A, R&D, and Dept/Amort Expenses | 20.56 | 20.62 | 20.30 | 20.45 | 22.20 |
Income After SG&A, R&D, and Dept/Amort Expenses | -7.44 | -9.14 | -9.24 | -8.46 | -8.69 |
Non-Operating Income | 0.87 | 0.94 | 0.92 | 0.90 | 0.84 |
Interest Expense | 0.07 | 0.08 | 0.08 | 0.08 | 0.03 |
Pretax Income | -6.64 | -8.27 | -8.41 | -7.63 | -7.88 |
Income Taxes | 0.98 | 0.37 | 1.22 | -0.40 | 0.56 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | -0.73 | -0.76 | -0.91 | -0.92 | -0.73 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -8.34 | -9.40 | -10.54 | -8.15 | -9.17 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -8.34 | -9.40 | -10.54 | -8.15 | -9.17 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 38.48 | 37.71 | 36.82 | 36.01 | 35.25 |
Diluted EPS Before Non-Recurring Items | -0.21 | -0.24 | -0.28 | -0.22 | -0.25 |
Diluted Net EPS (GAAP) | -0.22 | -0.25 | -0.28 | -0.23 | -0.26 |